Product-Quality Risks Incorrect amino-acid sequence Free peptide supplied as an undeclared salt Incorrect acetate content Incorrect net peptide quantity Deletion or insertion sequences Oxidation of the tryptophan residue Hydrolytic degradation Peptide aggregates or complexes Residual synthesis reagents Residual solvents Unverified bacterial-endotoxin control Unverified microbiological quality Certificates unrelated to the supplied batch Damage during uncontrolled storage or transport Limited adverse-event reports do not establish safety A product without widespread regulated clinical use will not generate a mature pharmacovigilance database
Begin Feeling the Difference
The only references to compounded products appear in the smallest, lightest colored font used in the ad as fleeting disclosures on the bottom of the screen for roughly 6 seconds, where it could potentially be blocked by closed captions or different TV screen ratios
Still, if a patient has an underlying arrhythmia or heart disease, even small changes in heart rate could trigger palpitations or other symptoms
It led Goucher to comment that she "was very concerned (about Dr
Its molecular structure was optimized through genetic engineering technology: an additional 13 amino acids were added to the N-terminus of natural IGF-1 (70 amino acids, molecular weight 7.4 kDa) to form a long-chain structure of 83 amino acids (molecular weight 9.11 kDa), and the third glutamic acid (Glu) was replaced with arginine (Arg), hence the name "R3"
